normative
COVID Justifies Massive Vaccine Investment And Capacity At Risk
Because the world economy is losing $500 billion every month due to COVID, it is worth investing heavily in developing a vaccine and getting many 'shots on goal' despite high failure risk; since private returns from building large factories before a vaccine is proven fall far below social returns, governments should use a mix of push and pull incentives—up-front financing to build factories ahead of time plus rewards for success—and invest in supply-chain capacity, not just final vaccine production.
normativepending
Speaker
Michael KremerEvidence Quote
“the private returns from building out a very large factory for a vaccine before we know whether the vaccine is going to work... are much less than the social returns. In this particular case, it probably makes sense for governments to offer to cover”
Created: 6/12/2026, 4:59:08 PM
Your notes
Loading notes...